메뉴 건너뛰기




Volumn 32, Issue 8, 2007, Pages 631-634

Tumor-induced osteomalacia: A case of diagnostic dilemma

Author keywords

Adrenal; Octreotide; Parathyroid; Thyroid; Tumor induced osteomalacia

Indexed keywords

ALKALINE PHOSPHATASE; FIBROBLAST GROWTH FACTOR 23; MEDRONATE TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OCTREOTIDE; PENTETREOTIDE IN 111; PERTECHNETIC ACID TC 99M; PHOSPHATE; TRACER;

EID: 34547690956     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3180a1ad1d     Document Type: Article
Times cited : (12)

References (8)
  • 1
    • 0032710053 scopus 로고    scopus 로고
    • Bone scintigraphy and metabolic disorders
    • Mari C, Catafau A, Carrio I. Bone scintigraphy and metabolic disorders. Q J Nucl Med. 1999;43:259-267.
    • (1999) Q J Nucl Med , vol.43 , pp. 259-267
    • Mari, C.1    Catafau, A.2    Carrio, I.3
  • 3
    • 0035321525 scopus 로고    scopus 로고
    • Tumour-induced osteomalacia
    • Drezner M. Tumour-induced osteomalacia. Rev Endocr Metab Disord. 2001;2:175-186.
    • (2001) Rev Endocr Metab Disord , vol.2 , pp. 175-186
    • Drezner, M.1
  • 4
    • 18744371012 scopus 로고    scopus 로고
    • Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia
    • Yamazaki Y, Okazaki R, Shibata M, et al. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab. 2002;87:4957-4960.
    • (2002) J Clin Endocrinol Metab , vol.87 , pp. 4957-4960
    • Yamazaki, Y.1    Okazaki, R.2    Shibata, M.3
  • 5
    • 0036019481 scopus 로고    scopus 로고
    • Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin
    • Fukumoto S, Yamashita T. Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin. Curr Opin Nephrol Hypertens. 2002;11:385-389.
    • (2002) Curr Opin Nephrol Hypertens , vol.11 , pp. 385-389
    • Fukumoto, S.1    Yamashita, T.2
  • 6
    • 14944360740 scopus 로고    scopus 로고
    • Octreotide therapy for tumor-induced osteomalacia
    • Seufert J, Ebert K, Muller J, et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med. 2001;345:1883-1888.
    • (2001) N Engl J Med , vol.345 , pp. 1883-1888
    • Seufert, J.1    Ebert, K.2    Muller, J.3
  • 7
    • 33748891023 scopus 로고    scopus 로고
    • Coexisting hyperparathyroidism and oncogenic osteomalacia: Sestamibi and somatostatin receptor scintigraphy
    • Nguyen BD. Coexisting hyperparathyroidism and oncogenic osteomalacia: sestamibi and somatostatin receptor scintigraphy. Clin Nucl Med. 2006;31:648-651.
    • (2006) Clin Nucl Med , vol.31 , pp. 648-651
    • Nguyen, B.D.1
  • 8
    • 0036705952 scopus 로고    scopus 로고
    • Bone and In-111 octreotide imaging in oncogenic osteomalacia: A case report
    • Garcia CA, Spencer RP. Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report. Clin Nucl Med. 2002;27:582-583.
    • (2002) Clin Nucl Med , vol.27 , pp. 582-583
    • Garcia, C.A.1    Spencer, R.P.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.